S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Better Than Oil Stocks (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Top Analyst Exposes Imminent Crisis Hurtling Towards America (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Better Than Oil Stocks (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Better Than Oil Stocks (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Top Analyst Exposes Imminent Crisis Hurtling Towards America (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Better Than Oil Stocks (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Better Than Oil Stocks (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Top Analyst Exposes Imminent Crisis Hurtling Towards America (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Better Than Oil Stocks (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Better Than Oil Stocks (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
Top Analyst Exposes Imminent Crisis Hurtling Towards America (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Better Than Oil Stocks (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
NASDAQ:PIII

P3 Health Partners (PIII) Stock Forecast, Price & News

$1.70
-0.03 (-1.73%)
(As of 10/3/2023 ET)
Compare
Today's Range
$1.63
$1.73
50-Day Range
$1.31
$2.79
52-Week Range
$0.70
$6.02
Volume
355,161 shs
Average Volume
463,823 shs
Market Capitalization
$533.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

P3 Health Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
193.3% Upside
$5.00 Price Target
Short Interest
Bearish
8.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.18mentions of P3 Health Partners in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$1.43 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.96) to ($0.73) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

676th out of 966 stocks

Health Services Industry

7th out of 12 stocks


PIII stock logo

About P3 Health Partners (NASDAQ:PIII) Stock

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

PIII Price History

PIII Stock News Headlines

BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
BTIG Keeps Their Buy Rating on P3 Health Partners (PIII)
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
P3 Health Partners On Solid Path To Profitability
See More Headlines
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

PIII Company Calendar

Last Earnings
8/07/2023
Today
10/03/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PIII
Fax
N/A
Employees
600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+193.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-270,130,000.00
Pretax Margin
-59.36%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$42.63 per share
Book Value
$0.15 per share

Miscellaneous

Free Float
259,334,000
Market Cap
$533.12 million
Optionable
Not Optionable
Beta
1.39
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Sherif Abdou F.A.C.E.P. (Age 62)
    FACP, M.D., Co-Founder, CEO & Director
    Comp: $7.1M
  • Dr. Amir Bacchus M.B.A. (Age 58)
    M.D., Co-Founder, Chief Medical Officer & Director
    Comp: $4.3M
  • Mr. Atul Kavthekar
    CFO & Chief Accounting Officer
  • Mr. William Bettermann
    Exec. VP & COO
  • Mr. Devery Goodey
    Sr. VP of Technology
  • Ms. Karen Blomquist
    VP of Investor Relations
  • Ms. Jessica Puathasnanon
    Chief Legal Officer, Gen. Counsel & Sec.
  • Roy Youngblood
    Director of Compliance
  • Ms. Kassi Belz APR
    Exec. VP of Communications, Culture & Engagement
  • Ms. Lorie Glisson CPA
    Florida Market Pres













PIII Stock - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings
or view top-rated stocks.

What is P3 Health Partners' stock price forecast for 2023?

2 brokerages have issued 1 year price objectives for P3 Health Partners' stock. Their PIII share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 193.3% from the stock's current price.
View analysts price targets for PIII
or view top-rated stocks among Wall Street analysts.

How have PIII shares performed in 2023?

P3 Health Partners' stock was trading at $1.84 on January 1st, 2023. Since then, PIII shares have decreased by 7.3% and is now trading at $1.7050.
View the best growth stocks for 2023 here
.

Are investors shorting P3 Health Partners?

P3 Health Partners saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 4,140,000 shares, an increase of 36.2% from the August 31st total of 3,040,000 shares. Based on an average daily trading volume, of 472,000 shares, the short-interest ratio is currently 8.8 days. Currently, 8.5% of the company's shares are short sold.
View P3 Health Partners' Short Interest
.

When is P3 Health Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our PIII earnings forecast
.

How were P3 Health Partners' earnings last quarter?

P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings results on Monday, August, 7th. The company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.24) by $0.15. The firm earned $329.09 million during the quarter, compared to analyst estimates of $303.30 million. P3 Health Partners had a negative trailing twelve-month return on equity of 2,471.27% and a negative net margin of 10.92%.

What guidance has P3 Health Partners issued on next quarter's earnings?

P3 Health Partners issued an update on its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.25 billion, compared to the consensus revenue estimate of $1.24 billion.

What is P3 Health Partners' stock symbol?

P3 Health Partners trades on the NASDAQ under the ticker symbol "PIII."

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is P3 Health Partners' stock price today?

One share of PIII stock can currently be purchased for approximately $1.71.

How much money does P3 Health Partners make?

P3 Health Partners (NASDAQ:PIII) has a market capitalization of $533.12 million and generates $1.05 billion in revenue each year. The company earns $-270,130,000.00 in net income (profit) each year or ($2,260.8101) on an earnings per share basis.

How many employees does P3 Health Partners have?

The company employs 600 workers across the globe.

How can I contact P3 Health Partners?

P3 Health Partners' mailing address is 2045 W GRAND AVE STUITE B, CHICAGO IL, 60612. The official website for the company is foresightacq.com. The company can be reached via phone at 702-910-3950 or via email at shalper@lifesciadvisors.com.

This page (NASDAQ:PIII) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -